Pal-ing, Jeneva M.
HRN: 26-79-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2025
COTRIMOXAZOLE 960MG (TAB)
03/21/2025
03/28/2025
PO
800/160
MWF
Sle
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes